AI In-Brief

Thailand News in Brief

Thai PBS World

Thailand and the world, every day

AI can make mistakes. Please double-check.

Thailand launches third phase of GPO’s inactivated COVID vaccine trials

13 Sept 11:24 Key points summarised by AI

Thailand's Government Pharmaceutical Organisation (GPO) commences Phase 3 human trials for its HXP-GPOVac inactivated COVID vaccine, enrolling 4,000 volunteers.
Trials involve administering two vaccine doses to each volunteer, with assessments focusing on immunity levels, safety, and comparative efficacy against the AstraZeneca vaccine for booster use.
Successful completion of this phase aims for emergency registration with the Thai FDA by mid-next year, significantly bolstering Thailand's vaccine security and reducing reliance on imports.
Public Health Minister Anutin Charnvirakul highlights the vaccine's safety due to its inactivated nature, noting its development with support from PATH and a prototype from US institutions.

Yesterday 09:24 Key points summarised by AI

Thailand secured a US$200 million loan from the World Bank to significantly invest in clean energy and low-carbon urban development initiatives.
The program aims to drive clean energy funding and low-carbon growth, ensuring a just transition for small and medium-sized enterprises, workers, farmers, and local communities.
Channelled through the Export-Import Bank of Thailand, the loan will fund energy efficiency upgrades in public buildings and industrial areas, including rooftop solar installations and electrical system modernizations, reducing initial capital burdens via Energy Service Companies (ESCOs).